Trials / Completed
CompletedNCT02231008
Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS
A Double-blind, Randomized, Two-period Crossover Study Evaluating the Effects of Tasimelteon vs. Placebo on Sleep Disturbances of Individuals With Smith-Magenis Syndrome (SMS)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Vanda Pharmaceuticals · Industry
- Sex
- All
- Age
- 3 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate tasimelteon vs. placebo on sleep disturbances of individuals with Smith-Magenis Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tasimelteon | |
| DRUG | placebo |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2018-11-19
- Completion
- 2022-01-01
- First posted
- 2014-09-03
- Last updated
- 2022-11-18
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02231008. Inclusion in this directory is not an endorsement.